Antibiotic Treatment for Stye
For a stye (hordeolum), topical erythromycin ophthalmic ointment applied directly to the affected eyelid up to six times daily is the recommended first-line antibiotic treatment. 1
Understanding Styes
A stye (hordeolum) is a localized infection of an eyelid gland, typically caused by Staphylococcus bacteria. Styes can be:
- Internal (affecting meibomian glands)
- External (affecting glands of Zeis or Moll)
Treatment Approach
First-Line Treatment
- Topical Erythromycin Ophthalmic Ointment
Alternative Topical Antibiotics
If erythromycin is unavailable or ineffective:
Bacitracin ophthalmic ointment
- Apply to eyelid margins one or more times daily 3
- Particularly effective for anterior blepharitis
Topical tobramycin/dexamethasone ophthalmic suspension
- Consider for cases with significant inflammation 3
- Note: Combination antibiotic-steroid preparations should be used with caution due to potential steroid-related complications
For Severe or Recurrent Cases
For styes that don't respond to topical treatment or in cases of recurrent infection:
- Oral antibiotics options:
Adjunctive Measures
In addition to antibiotic therapy:
Warm compresses
- Apply to affected eyelid for 5-10 minutes, 3-4 times daily
- Helps promote drainage and resolution
Eyelid hygiene
- Gentle cleansing of eyelid margins
- Removes debris and reduces bacterial load
Important Considerations
Tetracyclines (doxycycline, minocycline):
- Contraindicated in pregnancy and children under 8 years 3
- May cause photosensitivity and gastrointestinal upset
Duration of therapy:
When to refer to ophthalmology:
- No improvement after 48-72 hours of treatment
- Visual changes
- Spreading infection/cellulitis
- Recurrent styes
Evidence Quality
The evidence for antibiotic treatment of styes is primarily based on clinical practice guidelines rather than high-quality randomized controlled trials. A Cochrane review found no randomized controlled trials specifically evaluating nonsurgical treatments for acute internal hordeolum 4. However, clinical practice guidelines from ophthalmology societies consistently recommend topical antibiotics as first-line therapy, with oral antibiotics reserved for more severe or recurrent cases.
The FDA-approved labeling for erythromycin ophthalmic ointment supports its use for superficial ocular infections 1, making it an appropriate first-line choice for styes.